Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Ong

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|May 5, 2007
Beta blockers in hypertension and cardiovascular diseaseH T Ong
The Medical Journal of Malaysia|June 1, 1993
Cholesterol reduction therapy: a double-edged knifeH T Ong
Singapore Medical Journal|August 30, 2008
Cardiovascular outcomes in the comparative hypertension drug trials: more consensus than controversyH T Ong
The Journal of Family Practice|September 4, 2007
What we really need to do to reduce cardiovascular events in hypertensive patientsH T Ong
JAMA|April 24, 2003
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitorsH T Ong
Neurology|March 17, 2000
Benign childhood epilepsy with centrotemporal spikes: is it always benign?H T Ong, E Wyllie
The Medical Journal of Malaysia|October 27, 2009
Selecting antihypertensive medication in patients with essential hypertension in MalaysiaH T Ong, G Rozina
Brain & Development|November 10, 2001
Epidemiology of West syndrome in SingaporeW L Lee, H T Ong
Lancet (London, England)|April 9, 2008
Cholesterol, statins, and mortalityH T Ong, A G Haniffah
Singapore Medical Journal|October 1, 1991
Early management of myocardial infraction: a report from the Waikato Hospital, New ZealandH T Ong, D H Friedlander
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|May 5, 2007
Beta blockers in hypertension and cardiovascular diseaseH T Ong
The Medical Journal of Malaysia|June 1, 1993
Cholesterol reduction therapy: a double-edged knifeH T Ong
Singapore Medical Journal|August 30, 2008
Cardiovascular outcomes in the comparative hypertension drug trials: more consensus than controversyH T Ong
The Journal of Family Practice|September 4, 2007
What we really need to do to reduce cardiovascular events in hypertensive patientsH T Ong
JAMA|April 24, 2003
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitorsH T Ong
Neurology|March 17, 2000
Benign childhood epilepsy with centrotemporal spikes: is it always benign?H T Ong, E Wyllie
The Medical Journal of Malaysia|October 27, 2009
Selecting antihypertensive medication in patients with essential hypertension in MalaysiaH T Ong, G Rozina
Brain & Development|November 10, 2001
Epidemiology of West syndrome in SingaporeW L Lee, H T Ong
Lancet (London, England)|April 9, 2008
Cholesterol, statins, and mortalityH T Ong, A G Haniffah
Singapore Medical Journal|October 1, 1991
Early management of myocardial infraction: a report from the Waikato Hospital, New ZealandH T Ong, D H Friedlander
Pageof 5